Skip to content
  • Pharma SOP’s
  • Schedule M
  • Pharma tips
  • Pharma Stability Studies

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Tag: Risk management in GMP

The Role of PMDA GMP in Preventing Pharmaceutical Contamination

Posted on December 19, 2024 By digi

The Role of PMDA GMP in Preventing Pharmaceutical Contamination The Role of PMDA GMP in Preventing Pharmaceutical Contamination Introduction to Pharmaceutical Contamination and PMDA GMP Pharmaceutical contamination is a serious risk that can undermine the safety, efficacy, and quality of drug products, potentially endangering patient health. In Japan, the Pharmaceutical and Medical Devices Agency (PMDA)…

Read More “The Role of PMDA GMP in Preventing Pharmaceutical Contamination” »

PMDA GMP Guidelines

How ANVISA GMP Helps with Drug Stability and Expiry Dates

Posted on December 19, 2024 By digi

How ANVISA GMP Helps with Drug Stability and Expiry Dates How ANVISA GMP Helps with Drug Stability and Expiry Dates Introduction to ANVISA GMP and Drug Stability The National Health Surveillance Agency (ANVISA) is Brazil’s regulatory body responsible for overseeing the safety, quality, and efficacy of pharmaceutical products. One of the key frameworks enforced by…

Read More “How ANVISA GMP Helps with Drug Stability and Expiry Dates” »

GMP in Latin America (ANVISA, COFEPRIS)

How Schedule M (Revised) GMP Standards Affect the Pharmaceutical Supply Chain in India

Posted on December 19, 2024 By digi

How Schedule M (Revised) GMP Standards Affect the Pharmaceutical Supply Chain in India The Impact of Schedule M (Revised) GMP Standards on India’s Pharmaceutical Supply Chain Introduction to Schedule M (Revised) and the Pharmaceutical Supply Chain The pharmaceutical supply chain is a complex network encompassing raw material procurement, manufacturing, storage, distribution, and delivery to end-users….

Read More “How Schedule M (Revised) GMP Standards Affect the Pharmaceutical Supply Chain in India” »

SCHEDULE - M - Revised

How EMA GMP Guidelines Impact Drug Stability and Shelf Life

Posted on December 19, 2024 By digi

How EMA GMP Guidelines Impact Drug Stability and Shelf Life Ensuring Drug Stability and Shelf Life with EMA GMP Guidelines Introduction to Drug Stability and EMA GMP Guidelines Drug stability and shelf life are critical aspects of pharmaceutical manufacturing, directly affecting the efficacy, safety, and quality of medicinal products. The European Medicines Agency (EMA)’s Good…

Read More “How EMA GMP Guidelines Impact Drug Stability and Shelf Life” »

EMA GMP Guidelines

The Importance of TGA GMP Documentation and Record Keeping

Posted on December 19, 2024 By digi

The Importance of TGA GMP Documentation and Record Keeping Ensuring Compliance Through TGA GMP Documentation and Record Keeping Introduction to TGA GMP Documentation and Record Keeping Documentation and record-keeping are critical pillars of Good Manufacturing Practices (GMP) as enforced by the Therapeutic Goods Administration (TGA) in Australia. These practices ensure the safety, efficacy, and quality…

Read More “The Importance of TGA GMP Documentation and Record Keeping” »

TGA GMP Guidelines

How MHRA GMP Compliance Affects Pharmaceutical Product Stability

Posted on December 19, 2024 By digi

How MHRA GMP Compliance Affects Pharmaceutical Product Stability Ensuring Pharmaceutical Product Stability with MHRA GMP Compliance Introduction to Pharmaceutical Stability and MHRA GMP Pharmaceutical product stability is a critical aspect of drug development and manufacturing, ensuring that medicines remain safe, effective, and of high quality throughout their shelf life. The Medicines and Healthcare products Regulatory…

Read More “How MHRA GMP Compliance Affects Pharmaceutical Product Stability” »

MHRA GMP Guidelines

Common WHO GMP Violations and How to Avoid Them

Posted on December 19, 2024 By digi

Common WHO GMP Violations and How to Avoid Them Understanding Common WHO GMP Violations and Strategies to Avoid Them Introduction to WHO GMP Compliance Adhering to the World Health Organization (WHO)’s Good Manufacturing Practices (GMP)) is essential for ensuring the quality, safety, and efficacy of pharmaceutical products. However, achieving and maintaining compliance can be challenging,…

Read More “Common WHO GMP Violations and How to Avoid Them” »

WHO GMP Guidelines

How to Leverage NMPA GMP for Regulatory Approvals in China

Posted on December 19, 2024 By digi

How to Leverage NMPA GMP for Regulatory Approvals in China How to Leverage NMPA GMP for Regulatory Approvals in China Introduction to NMPA GMP and Regulatory Approvals in China The pharmaceutical industry in China is tightly regulated by the National Medical Products Administration (NMPA), formerly known as the China Food and Drug Administration (CFDA). NMPA…

Read More “How to Leverage NMPA GMP for Regulatory Approvals in China” »

NMPA GMP Guidelines

How PMDA GMP Ensures Compliance in Pharma Manufacturing Operations

Posted on December 18, 2024 By digi

How PMDA GMP Ensures Compliance in Pharma Manufacturing Operations How PMDA GMP Ensures Compliance in Pharma Manufacturing Operations Introduction to PMDA GMP Compliance in Pharmaceutical Manufacturing In the highly regulated pharmaceutical industry, ensuring that drug products are manufactured in accordance with Good Manufacturing Practices (GMP) is critical to ensuring their safety, efficacy, and quality. In…

Read More “How PMDA GMP Ensures Compliance in Pharma Manufacturing Operations” »

PMDA GMP Guidelines

TGA GMP Compliance for Pharmaceutical Manufacturers Exporting to Australia

Posted on December 18, 2024 By digi

TGA GMP Compliance for Pharmaceutical Manufacturers Exporting to Australia How Pharmaceutical Manufacturers Can Ensure TGA GMP Compliance for Export to Australia Introduction to TGA GMP Compliance for Export Pharmaceutical manufacturers exporting to Australia must adhere to the stringent Good Manufacturing Practices (GMP) standards enforced by the Therapeutic Goods Administration (TGA). These regulations ensure that imported…

Read More “TGA GMP Compliance for Pharmaceutical Manufacturers Exporting to Australia” »

TGA GMP Guidelines

Posts pagination

Previous 1 … 81 82 83 … 99 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • GMP Blog

Risk management in GMP

  • How Schedule M Revised Impacts Pharmaceutical Research and Development (R&D) in India
  • How to Streamline Your GMP Processes to Meet EMA and MHRA Requirements
  • Future Trends in Schedule M Revised Compliance and Its Impact on the Indian Pharmaceutical Industry
  • How to Build a Culture of GMP Compliance in Pharmaceutical Manufacturing in Europe
  • How Schedule M Revised Contributes to the Overall Quality Assurance of Indian Pharmaceutical Products
  • How to Ensure GMP Compliance for Pharmaceutical Drug Products in Europe
  • The Role of Regulatory Bodies in Enforcing GMP for Pharmaceutical Manufacturing in Europe
  • The Role of Data Integrity in Compliance with Schedule M Revised for Indian Pharmaceutical Manufacturers
  • How MHRA Ensures GMP Compliance in the UK Pharmaceutical Manufacturing Sector
  • Best Practices for GMP Compliance in High-Risk Drug Manufacturing in Emerging Markets

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme